MuscleGuyinNY
Banned
Who's used GH products and what were your experiences?
are you referring to real injectable GH or BS Gh supps?
muscleguy how's your giant stack going?
Real, expensive, GH (although I've never tried it myself) is extremely effective (and expensive, as I said before). All the sprays, or cheap oral gh products are worthless. Stuff like Powerfull works to increase the body's natural production of GH, but the effects on each individual vary quite a bit.
PGHt - awesome, two thumbs up. Good luck buying it now.
Somnidren GH - just started taking it, but so far sleep is amazing. We'll see if I get any signs pointing to GH release.
It generally, is not orally bioavailable.
All the sprays, or cheap oral gh products are worthless.
Nippon Naibunpi Gakkai Zasshi. 1987 Aug 20;63(8):934-46. Links
[Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases][Article in Japanese]
Mitsuhashi S, Yamasaki R, Miyazaki S, Saito H, Saito S.
First Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.
The responses of plasma growth hormone-releasing hormone (GHRH) and growth hormone (GH) to oral administration of L-dopa were studied in normal subjects and patients with various endocrine and metabolic diseases to clarify the pathophysiological role of the GHRH-GH axis. In normal subjects, the plasma GHRH concentration was increased from the basal value of 9.8 +/- 1.4 pg/ml (mean +/- SE) to 34.8 +/- 3.1 pg/ml at 30 approximately 90 min after oral administration of 500 mg L-dopa, followed by a rise of GH release (plasma GH level from less than 1 ng/ml to 21.7 +/- 4.7 ng/ml) in most cases, indicating that L-dopa stimulates GH secretion via hypothalamic GHRH. On L-dopa administration, no apparent increases in both plasma GHRH and GH concentrations were observed in patients with hypothalamic hypopituitarism, whereas GHRH administration induced almost normal GH response. In patients with acromegaly, the plasma levels of GHRH remained stationary after the L-dopa administration and did not correlate with plasma GH levels. In subjects with simple obesity, the responses of plasma GHRH (peak 13.2 +/- 1.2 pg/ml) and GH (peak 4.3 +/- 1.7 ng/ml) to L-dopa were significantly lower than those in normal subjects (p less than 0.01). In patients with primary hypothyroidism, peak levels of plasma GHRH (12.6 +/- 1.3 pg/ml) and GH (2.4 +/- 0.6 ng/ml) were significantly lower than those in normal subjects (p less than 0.01). In patients with non-insulin dependent diabetes mellitus (NIDDM), the responses of GHRH and GH were divided into 2 groups; in the responder the peak values of GHRH and GH were 19.4 +/- 8.6 pg/ml and 12.2 +/- 1.4 ng/ml and in the low or non responder 14.7 +/- 1.5 pg/ml and 2.0 +/- 0.6 ng/ml, respectively. Between both groups, there was a significant difference in the values of fasting blood sugar and HbA1 and mean suffering period. These findings suggest that GH secretion evoked by the L-dopa administration is induced by GHRH released from the hypothalamus, and impairment of GH secretion associated with simple obesity, primary hypothyroidism, or NIDDM may be in part attributed to insufficiency of GHRH release from the hypothalamus, and indicate that L-dopa test is clinically useful for evaluating the ability of intrinsic GHRH release in such diseased states.
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
* Katzenschlager R,
* Evans A,
* Manson A,
* Patsalos PN,
* Ratnaraj N,
* Watt H,
* Timmermann L,
* Van der Giessen R,
* Lees AJ.
National Hospital for Neurology and Neurosurgery, London, UK.
BACKGROUND: The seed powder of the leguminous plant, Mucuna pruriens has long been used in traditional Ayurvedic Indian medicine for diseases including parkinsonism. We have assessed the clinical effects and levodopa (L-dopa) pharmacokinetics following two different doses of mucuna preparation and compared them with standard L-dopa/carbidopa (LD/CD). METHODS: Eight Parkinson's disease patients with a short duration L-dopa response and on period dyskinesias completed a randomised, controlled, double blind crossover trial. Patients were challenged with single doses of 200/50 mg LD/CD, and 15 and 30 g of mucuna preparation in randomised order at weekly intervals. L-dopa pharmacokinetics were determined, and Unified Parkinson's Disease Rating Scale and tapping speed were obtained at baseline and repeatedly during the 4 h following drug ingestion. Dyskinesias were assessed using modified AIMS and Goetz scales. RESULTS: Compared with standard LD/CD, the 30 g mucuna preparation led to a considerably faster onset of effect (34.6 v 68.5 min; p = 0.021), reflected in shorter latencies to peak L-dopa plasma concentrations. Mean on time was 21.9% (37 min) longer with 30 g mucuna than with LD/CD (p = 0.021); peak L-dopa plasma concentrations were 110% higher and the area under the plasma concentration v time curve (area under curve) was 165.3% larger (p = 0.012). No significant differences in dyskinesias or tolerability occurred. CONCLUSIONS: The rapid onset of action and longer on time without concomitant increase in dyskinesias on mucuna seed powder formulation suggest that this natural source of L-dopa might possess advantages over conventional L-dopa preparations in the long term management of PD. Assessment of long term efficacy and tolerability in a randomised, controlled study is warranted.
Beans (Mucuna Pruriens) For Parkinson?s Disease:
An Herbal Alternative
Bala V. Manyam, M.D., NPF Center of Excellence Plummer Movement Disorders Center Department of Neurology
Glenn R. Cryer, Scientific Publications and Biomedical Communications
Scott & White Clinic and Texas A&M University Health Science System College of Medicine
.....To establish how Mucuna would compare to synthetic L-DOPA, experiments were undertaken in animal models of Parkinson?s disease. Two different doses of synthetic L-DOPA and two different doses of Mucuna were administered making sure that the amount of L-DOPA present is the same in Mucuna as was the doses of synthetic L-DOPA. The effects of the drugs were tested using a specially designed instrument called "Rotometer." Dose for dose, Mucuna was two to three times more effective than equivalent amounts of synthetic L-DOPA. This suggests that Mucuna may contain compounds that make L-DOPA function better such as carbidopa, tolcapone (Tasmar), or entacapone (COMTan). It may also suggest that Mucuna independently improve symptoms of Parkinson?s disease. Although quite encouraging, more research is needed to confirm these findings. This work was done at the time when the United States Congress established the Office of Alternative Medicine in the National Institute of Health and the work was one of the first to receive funding for alternative medicine....
Neuroprotective effects of the antiparkinson drug Mucuna pruriens.
* Manyam BV,
* Dhanasekaran M,
* Hare TA.
Department of Neurology, Health Science Center College of Medicine, Temple, TX 76508, USA. [email protected]
Mucuna pruriens possesses significantly higher antiparkinson activity compared with levodopa in the 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease. The present study evaluated the neurorestorative effect of Mucuna pruriens cotyledon powder on the nigrostriatal tract of 6-OHDA lesioned rats. Mucuna pruriens cotyledon powder significantly increased the brain mitochondrial complex-I activity but did not affect the total monoamine oxidase activity (in vitro). Unlike synthetic levodopa treatment, Mucuna pruriens cotyledon powder treatment significantly restored the endogenous levodopa, dopamine, norepinephrine and serotonin content in the substantia nigra. Nicotine adenine dinucleotide (NADH) and coenzyme Q-10, that are shown to have a therapeutic benefit in Parkinson's disease, were present in the Mucuna pruriens cotyledon powder. Earlier studies showed that Mucuna pruriens treatment controls the symptoms of Parkinson's disease. This additional finding of a neurorestorative benefit by Mucuna pruriens cotyledon powder on the degenerating dopaminergic neurons in the substantia nigra may be due to increased complex-I activity and the presence of NADH and coenzyme Q-10. Copyright (c) 2004 John Wiley & Sons, Ltd.
PMID: 15478206 [PubMed - indexed for MEDLINE]
Mullet, wouldn't/couldn't some of the ineffectiveness of PowerFull/L-dopa be attributed to the average users eating habits? Most guys who are taking it eat right before bed, and some have carbs in their systems, which could interfere with GH release?
Most bodybuilders won't want to eat their last meal 2-3 hours before bed.
Mullet, wouldn't/couldn't some of the ineffectiveness of PowerFull/L-dopa be attributed to the average users eating habits? Most guys who are taking it eat right before bed, and some have carbs in their systems, which could interfere with GH release?
Most bodybuilders won't want to eat their last meal 2-3 hours before bed.
Mullet: I think you misunderstood me. I was refering to taking GH (in the form of oral sprays and such) directly into the system as being bio-unavailable. If you look at my first post, I mention Powerfull, and how it is a way to stimulate GH production (great product by the way, have had success with it). There are certainly orally bioavaliable ways to to increase GH naturally.
It's the insulin which blunts the GH response, and so as long as plasma levels have begun to clear, you're in the clear. 2-3 hours is a fairly long estimate, if you ate a meal containing carbohydrates at 9pm, by 11pm you could be fairly certain it would not effect PowerFULL. This all depends on individual glucose metabolism of course.
I think the larger issue is that PowerFULL produces short-term plasma increases of dopamine and GH, that are not sustained to the level of exogenous GH. Tolerance is also at work here, as the body adapts to the natural L-DOPA raising alkaloids in Mucuna. So, while the immediate dopamine-GH increase of PowerFULL is comparable to synthetics and pharmaceuticals, it is not sustained. Thus obviously not producing the results of a 6 month GH run.
This is not rhetoric either, the research is there. Objective measures of onset time, peak concentrations, and observed pathways through which Mucuna is raising dopamine and GH have been shown.
Oops, sorry buddy.
:cheers:
With synthetic HGH you get insulin resistance so if you go that route, you need some Anabolic pump.
I'm biased but if you look at the negative side of synthetic HGH. PowerFULL becomes much more attractive.
So, pure GH can only be injected?
No harm. You're still my boy.:cheers:
The cost, as well, is a huge reason PowerFULL is more atractive.
Someone posted and deleted the post stating all HGH products are garbage. Mullet was addressing the vanished post and quoted you by accident..
no worries dancebot NO MORE SUPPLEMENTS FOR mullet.
:rofl:
So, pure GH can only be injected?
I'll put it this way; the GH products you've seen (not the ones that increase GH production), unless they cost thousands of dollars, don't work.
Then, going the route of using products that stimulate GH production would be more worthy my time and money. I get it. Thanks.
Someone posted and deleted the post stating all HGH products are garbage. Mullet was addressing the vanished post and quoted you by accident..
no worries dancebot NO MORE SUPPLEMENTS FOR mullet.
:rofl:
That doesn't bode well for me, considering our disgusting year coming!!
:djparty: